Dates: March 18–19, 2025
Location: Dome Event Hall, Brussels
Visit the Official Event Website
Join Metabolon at the Microbiome Times Partnering Forum 2025
Metabolon is attending the Microbiome Times Partnering Forum 2025, an industry event bringing together experts in microbiome research, probiotics, and gut health innovations. This forum serves as a key meeting point for scientists, biopharma leaders, and regulatory professionals to explore the latest developments in microbiome-based therapeutics, precision nutrition, and next-generation probiotics.
About the Microbiome Times Partnering Forum 2025
The Microbiome Times Partnering Forum is a dedicated event focused on collaborations and business development in the microbiome space. With sessions covering scientific breakthroughs, clinical advancements, commercialization strategies, and regulatory pathways, attendees will gain valuable insights into the evolving microbiome industry.
The forum fosters partnerships between biotechs, pharma companies, and academic researchers, providing a platform for deal-making, funding opportunities, and strategic networking.
Scientific Themes and Program Highlights
The Microbiome Times Partnering Forum 2025 will feature discussions on the latest advancements in microbiome science, commercialization strategies, and investment opportunities, with key themes including:
- Microbiome and Human Health – Understanding the impact of gut microbiota on metabolic, immune, and neurological diseases.
- Microbiome-Based Drug Development – Advances in live biotherapeutics, postbiotics, and microbiome-derived therapeutics.
- Probiotics, Prebiotics, and Synbiotics – Novel formulations and efficacy data for gut health, dermatology, and metabolic conditions.
- Microbiome and Metabolomics – Unlocking the functional impact of microbial communities through metabolic profiling.
- Regulatory & Commercialization Strategies – Addressing challenges in clinical validation, regulatory approval, and market access.
Why Metabolon is Attending the Microbiome Times Partnering Forum 2025
Metabolon is at the forefront of microbiome research, delivering high-resolution metabolomics solutions that provide functional insights into microbial activity and host interactions. As microbiome research shifts toward high-volume data generation and integrated multiomics approaches, metabolomics has become an essential tool for biomarker discovery, microbiome-based drug development, and clinical success.
At the Microbiome Times Partnering Forum 2025, Metabolon will be discussing:
- Characterizing microbiome-derived metabolites, revealing their functional roles in human health, disease, and therapeutic response.
- Supporting microbiome-based drug discovery, helping biopharma partners develop next-generation probiotics and live biotherapeutics.
- Enabling multiomics data integration through our Integrated Bioinformatics Platform, combining metabolomics, metagenomics, and proteomics for comprehensive microbiome analysis.
- Uncovering novel biomarkers for gut health, immune modulation, and metabolic disorders, advancing clinical microbiome research and personalized medicine.
- Enhancing regulatory and commercial strategies by providing validated, high-quality metabolic data for product development and clinical validation.
With microbiome-targeted therapies gaining momentum, Metabolon provides unparalleled data quality, scalability, and actionable insights to accelerate research, development, and commercialization.
Meet us at the Microbiome Times Partnering Forum 2025 to learn how our cutting-edge metabolomics solutions can help transform microbiome innovation.
